Clinical trial
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell and Mesenchymal Stem Cell Lyophilisate
NCT04675970 is registered in ClinicalTrials.gov with Ukraine Association of Biobank as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell and Mesenchymal Stem Cell Lyophilisate
- Lead sponsor
- Ukraine Association of Biobank
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- September 30, 2025
- Enrollment
- 86 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
premature ovarian failure, primary ovarian insufficiency